Corvus Pharmaceuticals Inc
F:C17
Corvus Pharmaceuticals Inc
F:C17
Price:
12.84
EUR
0.9%
Market Cap:
€803.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Corvus Pharmaceuticals Inc
F:C17
|
US |
|
Blockmate Ventures Inc
XTSX:MATE
|
UK |
|
S
|
Shree Steel Wire Ropes Ltd
BSE:513488
|
IN |
|
Klingelnberg AG
F:2MK
|
CH |
|
Refex Industries Ltd
NSE:REFEX
|
IN |
|
H
|
Hove A/S
F:LL0
|
DK |
|
Zhejiang Publishing & Media Co Ltd
SSE:601921
|
CN |
|
Gefran SpA
F:GF7
|
IT |
|
C
|
Chubu Electric Power Co Inc
F:0C2
|
JP |
|
G
|
GuocoLand Ltd
XMUN:FS8
|
SG |
|
H
|
Hyprop Investments Ltd
JSE:HYP
|
ZA |
Wall St Price Targets
C17 Price Targets Summary
Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Wall Street analysts forecast C17 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for C17 is 15.45 EUR with a low forecast of 12.46 EUR and a high forecast of 20.15 EUR.
Lowest Forecast
Price Target
12.46
EUR
3% Downside
Average Forecast
Price Target
15.45
EUR
20% Upside
Highest Forecast
Price Target
20.15
EUR
57% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C17's stock price target?
Price Target
15.45
EUR
15.45
EUR
According to Wall Street analysts, the average 1-year price target for C17 is 15.45 EUR with a low forecast of 12.46 EUR and a high forecast of 20.15 EUR.
